Andreas Michael Schmitt1, Amanda Katharina Herbrand1, Anouk Hoogkamer1, Markus Joerger2, Stefan Diem2, 3, Urban Novak4, Lars G. Hemkens5, Benjamin Kasenda1, 6

1 University Hospital Basel, Department of Medical Oncology, Basel , Basel-Stadt, Schweiz
2 Cantonal Hospital St. Gallen, Department of Oncology and Hematology, St. Gallen, St.Gallen, Schweiz
3 Spital Grabs, Department of Oncology and Hematology, Grabs, St.Gallen, Schweiz
4 Bern University Hospital, Department of Medical Oncology, Bern, Bern, Schweiz
5 University Hospital Basel, Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, Basel , Basel-Stadt, Schweiz
6 Klinikum Stuttgart, Department of Hematology/Oncology and Palliative Care, Stuttgart, Baden-Württemberg, Deutschland

Reimbursement Reality for Off-label use in Swiss Cancer Care – A systematic empirical investigation